⸺ Synova Research
SS-31
Mitochondria-targeted tetrapeptide (elamipretide) studied for mitochondrial membrane stabilisation, ATP production and oxidative-stress protection in preclinical models.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About SS-31
SS-31 (also known as elamipretide or Bendavia) is a cell-permeable tetrapeptide that selectively targets the inner mitochondrial membrane. Researchers study it for its interaction with cardiolipin and its role in supporting mitochondrial structure, energy production and protection against oxidative damage.
⸺ Mechanism of Action
How it works
SS-31 binds selectively to cardiolipin in the inner mitochondrial membrane, stabilising cristae architecture and improving electron transport chain efficiency. In animal models this reduces reactive oxygen species generation and supports ATP synthesis under stress conditions.
⸺ Research
Areas of study
Mitochondrial function
Preclinical studies report improved mitochondrial respiration and ATP output in aged and stressed tissue models.
Oxidative stress
Animal research describes reduced ROS production and lipid peroxidation following SS-31 administration.
Cardiac and muscle models
Research has explored SS-31 in models of heart failure and skeletal-muscle dysfunction, with improved functional outcomes.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 736992-21-5
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
RTTA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
TRZT
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
SMGT
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.